Transformative power of insights in BioPharma development
How well are your processes captured? How readily findable is your process data? Do you have the right tools to transform your data into meaningful insight?
A typical BioPharma development company uses 30-50 different software tools and systems!
April 19, 2023 | 4pm BST, 11am ET, 8am PT
Despite the promises of the data connectivity and significant efficiency gains of BioPharma 4.0, a typical BioPharma development company uses 30-50 different tools and systems. This patchwork of platforms inevitably leads to data silos, integrity risks from manual/custom formatting for consolidation and traceability concerns. Consequently, the ability to make meaningful and speedy interpretations from trustworthy data, attributable to fully captured and searchable processes, alludes many across the industry. Ideas of performing advanced analytics and utilizing transformative tools such as digital twins for process simulation, remain a dream.
How well are your processes captured? How readily findable is your process data? Do you have the right tools to transform your data into meaningful insight?
By improving how data moieties are captured and contextualized in a digital data backbone and linking to an advanced analytics engine, we can expedite process understanding to enable faster decision making and ensure a view of data for knowledge transfer throughout the BioPharma lifecycle.
Join us to learn:
- How a holistic process-centric approach to data capture can ensure data is aligned and contextualized to generate meaningful insight for confident decisions
- How to build deeper understanding of process variables to unlock mysteries, ensure consistency where it matters most and open the door to more rapid process design
- How easy-to-use visualization tools and advanced analytics linked to a digital data backbone can streamline process optimization
Register Now
Meet our speaker
Michael Barnes
Lead Solutions Consultant, IDBS
Multidisciplinary Bench Scientist having worked in various roles/companies, from isolating rare and underrepresented cancers at the Broad Institute, to automating cell-based toxicology assays in a CRO setting. Prior to shifting to IDBS, I spent ~3 years in Pfizer’s BioProcess R&D Cell Line Development group, working to evaluate different vectors/expression systems and investigate phenotypic changes at a genotypic level.
More webinars
Democratizing access to AI/ML-powered insights to accelerate BioPharma process optimization
In this webinar, we share how the new IDBS Polar Insight data science engine speeds time-to-insight by providing advanced analytics…
Webinar | Build a faster, better CPV program in an external manufacturing network
Get a solid understanding of how modern data capture, verification and analysis techniques can drive better monitoring programs for commercial…
Webinar | Creation of a real time process data framework with external manufacturer to enhance process performance, technology transfer success and drive cost savings
Janssen looks at external and internal data sharing as a win-win application of digital technology that enables external manufacturers to…
i3 Japan 2022
i3 our premier annual customer event where we bring together science, IT and R&D business leaders to share ideas, create…